Results 261 to 270 of about 1,888,598 (318)

Immunosuppressive Drug Use in Limited Systemic Sclerosis: An International Survey

Arthritis Care &Research, EarlyView.
Objective Current guidelines recommend immunosuppressive treatment for diffuse cutaneous systemic sclerosis but are less clear on their use in limited cutaneous systemic sclerosis (lcSSc) in the absence of internal organ complications. We conducted an international survey to understand current immunosuppressive drug prescribing patterns in lcSSc ...
Sabrina Hoa, Yicheng Mu, Marie Hudson, Janet Pope   +3 more
wiley   +1 more source

Pharmacological Targeting of PI3K/Akt/mTOR and Wnt/GSK-3β Signaling in Oligodendrocyte Differentiation and Remyelination. [PDF]

Cells
Kim ME, Lee JS.
europepmc   +1 more source

Exploring the conformational landscape of adenylate kinase and beyond with protein folding models. [PDF]

Sci Rep
Bhasin A, Delaunay A, Saccon F, Fu Y.
europepmc   +1 more source

Structural insights into HRI kinase activity and inhibition. [PDF]

Biochem Soc Trans
Cao M, Masson GR.
europepmc   +1 more source

Constrained peptide mimics of the LRRK2 C-terminal Helix inhibits its kinase activity. [PDF]

Bioorg Chem
Chen T, Alexander KK, Martinez Fiesco JA, Naaldijk Y, Fasiczka R, Brahmia B, de la Cruz AA, LeClair TJ, Steude EG, Zhang P, Hilfiker S, Kennedy EJ.   +11 more
europepmc   +1 more source